Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Dr. Scott Koenig, M.D.,PhD$977.8M
Market Cap • 19/04/20242000
(há 24 anos)
2013
(11 years ago)
NASDAQ
Listagem
Rockville
Sede • Maryland357
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MGNXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.